Latest News in the pharma Industry

Policy & Regulation

FDA Approves ANDA of Loxapine Capsules

FDA Approves ANDA of Loxapine Capsules

9 Oct 2011

Lannett Company has received approval from the FDA for its Loxapine Capsules in 5mg, 10mg, 25mg and 50mg doses.

Read more 
India's Commerce Ministry Calls for Policy Measures to Boost Pharma Exports to China

India's Commerce Ministry Calls for Policy Measures to Boost Pharma Exports to China

8 Oct 2011

A strategic paper by the Indian Commerce Ministry calls for critical policy interventions and special efforts to increase the presence of Indian pharma industry in China.

Read more 
AstraZeneca Wins Japanese Approval for Faslodex

AstraZeneca Wins Japanese Approval for Faslodex

30 Sep 2011

AstraZeneca has received regulatory approval for its breast cancer drug Faslodex (fulvestrant) 500mg in Japan.

Read more 
Takeda Submits New Drug Application for TAK-085

Takeda Submits New Drug Application for TAK-085

30 Sep 2011

Takeda has submitted a New Drug Application in Japan for TAK-085 for the treatment of hyperlipidemia.

Read more 
HHS Launches New Initiative to Strengthen Primary Care

HHS Launches New Initiative to Strengthen Primary Care

29 Sep 2011

Under the new initiative, Medicare will work with commercial and state health insurance plans to offer additional support to primary care doctors who better coordinate care for their patients.

Read more 
Novartis Receives Japanese Regulatory Approval for Two Innovative Therapies

Novartis Receives Japanese Regulatory Approval for Two Innovative Therapies

28 Sep 2011

The Japanese regulators have approved Novartis' once-daily Gilenya (fingolimod) 0.5mg and Illaris (canakinumab) subcutaneous injection 150mg in the Japanese market.

Read more 
India Releases Guidelines for Conservation & Development of Medicinal Plants

India Releases Guidelines for Conservation & Development of Medicinal Plants

28 Sep 2011

The scheme released by India's Department of Ayush aims to promote availability of quality plant based raw material.

Read more 
Boehringer Ingelheim Receives EU Approval for Viramune Once-daily Formulation

Boehringer Ingelheim Receives EU Approval for Viramune Once-daily Formulation

28 Sep 2011

Boehringer Ingelheim has received European approval for its once-daily Viramune tablets for HIV treatment.

Read more 
Eisai Receives Canadian Approval of Banzel as Adjunctive Treatment for Severe Epilepsy Disorder

Eisai Receives Canadian Approval of Banzel as Adjunctive Treatment for Severe Epilepsy Disorder

26 Sep 2011

Canadian regulators have given approval of Banzel for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome.

Read more 
Tokai Secures Financing to Advance Cancer Drug Study

Tokai Secures Financing to Advance Cancer Drug Study

26 Sep 2011

Tokai Pharmaceuticals has received $23m funding in a Series D3 financing to support its ongoing clinical development of galeterone.

Read more 
Remicade Approved to Treat Ulcerative Colitis in Children Older Than 6 Years

Remicade Approved to Treat Ulcerative Colitis in Children Older Than 6 Years

26 Sep 2011

Janssen's Remicade has been approved by FDA to treat moderately to severely active ulcerative colitis in children older than 6 years who have had inadequate response to conventional therapy.

Read more 
FDA Approves Soliris for Rare Pediatric Blood Disorder

FDA Approves Soliris for Rare Pediatric Blood Disorder

26 Sep 2011

The FDA has approved Soliris to treat patients with atypical Hemolytic Uremic Syndrome that can lead to kidney failure and is also associated with increased risk of death and stroke.

Read more